Back to Archived Journals » Comparative Effectiveness Research » Volume 8

Cost-effectiveness of sunitinib as second-line treatment for gastrointestinal stromal tumor in the People’s Republic of China [Corrigendum]

Total article views   HTML views PDF downloads Totals
5,399 Dovepress* 5,399+ 657 6,056
Totals 5,399 657 6,056
*Since 24 January 2018

View citations on Google Scholar